bpc-157 safety evidence BPC-157: The peptide with big claims and scant clinical evidence bpc-157 safety |

PAR recommends that the only people who should take B12 shots are those with B12 deficiency who cannot absorb the vitamin when they take it orally

The long-term risks of TRT are still unknown, as many of these studies have limited follow-ups

If ultrasound imaging is inconclusive but clinical suspicion remains, an MRI scan may be warranted to further assess

A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent, wherein the therapeutic agent is an antioxidant or anti-apoptotic agent, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration